In a novel ABO-incompatible kidney transplantation, investigators converted the deceased donor kidney’s blood type.

Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.

(HealthDay News) — Two mechanisms of structural and functional retinal impairment based on papilledema severity have been identified among patients with idiopathic intracranial hypertension (IIH), ...

For patients with cardiac arrest and a shockable rhythm, automated external defibrillators (AEDs) in private homes improve outcomes but cannot be considered cost-effective at current pricing, ...